{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Other\" and posted_year = 2009 sorted by posted_date descending", "rows": [["FDA-2009-P-0272-0003", "FDA", "FDA-2009-P-0272", "FDA/CDER Response to Sanofi-aventis, U.S., LLC - Petition Partial Approval and Denial", "Other", "PPAD-Petition Partial Approval and Denial", "2009-12-31T05:00:00Z", 2009, 12, "2009-12-31T05:00:00Z", null, "2013-07-27T23:02:09Z", null, 0, 0, "0900006480a68fe7"], ["FDA-1995-S-0036-0109", "FDA", "FDA-1995-S-0036", "Report 38 - Baylor College of Medicine Public Disclosure on IND 100,681", "Other", "RPT-Report", "2009-12-31T05:00:00Z", 2009, 12, "2009-12-31T05:00:00Z", null, "2013-07-27T23:02:32Z", null, 0, 0, "0900006480a6b5ec"], ["FDA-2009-P-0598-0001", "FDA", "FDA-2009-P-0598", "James Matthew Weber - Citizen Petition", "Other", "CP-Citizen Petition", "2009-12-31T05:00:00Z", 2009, 12, "2009-12-31T05:00:00Z", null, "2012-03-06T19:35:08Z", null, 0, 0, "0900006480a74a4d"], ["FDA-2009-P-0298-0007", "FDA", "FDA-2009-P-0298", "FDA/CFSAN Interim Response to OVOS Natural Health, Inc. (Ullman, Shapiro & Ullman, LLP) - Letter", "Other", "LET-Letter", "2009-12-31T05:00:00Z", 2009, 12, "2009-12-31T05:00:00Z", null, "2013-08-11T04:36:59Z", null, 0, 0, "0900006480a69fe6"], ["FDA-2009-P-0598-0002", "FDA", "FDA-2009-P-0598", "Acknowledgement Letter to James Matthew Weber", "Other", "ACK-Acknowledgement Letter", "2009-12-31T05:00:00Z", 2009, 12, "2009-12-31T05:00:00Z", null, "2013-08-11T01:31:47Z", null, 0, 0, "0900006480a74a4e"], ["FDA-2008-D-0525-0013", "FDA", "FDA-2008-D-0525", "New Contrast Imaging Indication Considerations for Devices and Approved Drug and Biological Products:  Guidance for Industry", "Other", "Guidance", "2009-12-31T05:00:00Z", 2009, 12, "2009-12-31T05:00:00Z", null, "2024-11-07T22:12:12Z", null, 1, 0, "0900006480a77652"], ["FDA-2009-P-0282-0003", "FDA", "FDA-2009-P-0282", "FDA/CDRH to Mr. David S. Smith (Pepper Hamilton, LLP)", "Other", "LET-Letter", "2009-12-30T05:00:00Z", 2009, 12, "2009-12-30T05:00:00Z", null, "2013-07-27T23:03:28Z", null, 0, 0, "0900006480a7444f"], ["FDA-2009-P-0597-0031", "FDA", "FDA-2009-P-0597", "Acknowledgement Letter to GlaxoSmithKline", "Other", "ACK-Acknowledgement Letter", "2009-12-29T05:00:00Z", 2009, 12, "2009-12-29T05:00:00Z", null, "2013-08-11T03:05:59Z", null, 0, 0, "0900006480a6dd07"], ["FDA-2009-D-0591-0002", "FDA", "FDA-2009-D-0591", "Guidance to Pharmacies on Advance Compounding of Tamiflu Oral Suspension to Provide for Multiple Prescriptions", "Other", "GDL-Guidance (Supporting and Related Materials)", "2009-12-29T05:00:00Z", 2009, 12, "2009-12-29T05:00:00Z", null, "2024-11-07T22:11:11Z", null, 1, 0, "0900006480a73756"], ["FDA-2009-P-0597-0001", "FDA", "FDA-2009-P-0597", "GlaxoSmithKline (Ropes & Gray LLP) - Citizen Petition", "Other", "CP-Citizen Petition", "2009-12-29T05:00:00Z", 2009, 12, "2009-12-29T05:00:00Z", null, "2019-01-30T20:17:16Z", null, 0, 0, "0900006480a6c85b"], ["FDA-1996-P-0383-0001", "FDA", "FDA-1996-P-0383", "Fuisz Technologies Ltd - Citizen Petition", "Other", "CP-Citizen Petition", "2009-12-28T05:00:00Z", 2009, 12, "2009-12-28T05:00:00Z", null, "2009-12-28T20:30:15Z", null, 0, 0, "0900006480506ffd"], ["FDA-1996-P-0383-0002", "FDA", "FDA-1996-P-0383", "Fuisz Technologies Ltd - Letter", "Other", "LET-Letter", "2009-12-28T05:00:00Z", 2009, 12, "2009-12-28T05:00:00Z", null, "2009-12-28T20:30:17Z", null, 0, 0, "0900006480507008"], ["FDA-1984-P-0333-0001", "FDA", "FDA-1984-P-0333", "Petition Approval from Center for Drugs and Biologics to Sterling Drug Inc", "Other", "Approval", "2009-12-28T05:00:00Z", 2009, 12, "2009-12-28T05:00:00Z", null, "2022-05-17T20:03:37Z", null, 0, 0, "09000064805a9401"], ["FDA-1996-P-0383-0004", "FDA", "FDA-1996-P-0383", "Acknowledgement Letter to Fuisz Technologies LTD", "Other", "ACK-Acknowledgement Letter", "2009-12-28T05:00:00Z", 2009, 12, "2009-12-28T05:00:00Z", null, "2009-12-28T20:30:21Z", null, 0, 0, "0900006480a72ac2"], ["FDA-1996-P-0383-0003", "FDA", "FDA-1996-P-0383", "Fuisz Technologies Ltd. - Withdrawal", "Other", "CP-Citizen Petition", "2009-12-28T05:00:00Z", 2009, 12, "2009-12-28T05:00:00Z", null, "2013-07-27T21:20:27Z", null, 0, 0, "090000648050700a"], ["FDA-1984-P-0333-0002", "FDA", "FDA-1984-P-0333", "Acknowledgement Letter from Dockets Management Branch to Sterling Drug Inc", "Other", "Acknowledgement Letter/Receipt", "2009-12-28T05:00:00Z", 2009, 12, "2009-12-28T05:00:00Z", null, "2022-05-18T15:15:25Z", null, 0, 0, "0900006480a72b74"], ["FDA-2009-D-0600-0002", "FDA", "FDA-2009-D-0600", "Draft Guidance for Industry on Tobacco Health Document Submission - Guidance", "Other", "Guidance", "2009-12-28T05:00:00Z", 2009, 12, "2009-12-28T05:00:00Z", null, "2024-11-07T22:13:38Z", null, 1, 0, "0900006480a71ffb"], ["FDA-2009-P-0297-0003", "FDA", "FDA-2009-P-0297", "AllerQuest LLC to FDA - Withdrawal of Petition", "Other", "WDL-Withdrawal", "2009-12-23T05:00:00Z", 2009, 12, "2009-12-23T05:00:00Z", null, "2013-07-27T23:03:06Z", null, 0, 0, "0900006480a7087b"], ["FDA-2002-D-0223-0003", "FDA", "FDA-2002-D-0223", "An Acceptable Circular of Information for the Use of Human Blood and Blood Components - Level 2 Guidance", "Other", "GDL-Guidance (Supporting and Related Materials)", "2009-12-23T05:00:00Z", 2009, 12, "2009-12-23T05:00:00Z", null, "2024-11-07T22:12:43Z", null, 1, 0, "0900006480a700ff"], ["FDA-2009-P-0305-0001", "FDA", "FDA-2009-P-0305", "Hygeia II Medical Group Inc. - Citizen Petition", "Other", "CP-Citizen Petition", "2009-12-23T05:00:00Z", 2009, 12, "2009-12-23T05:00:00Z", null, "2020-05-05T14:43:19Z", null, 0, 0, "09000064809e79c6"], ["FDA-2009-P-0305-0002", "FDA", "FDA-2009-P-0305", "Acknowledgement Letter to Hygeia II Medical Group Inc.", "Other", "ACK-Acknowledgement Letter", "2009-12-23T05:00:00Z", 2009, 12, "2009-12-23T05:00:00Z", null, "2009-12-23T15:29:49Z", null, 0, 0, "09000064809e79c9"], ["FDA-1987-P-0230-0002", "FDA", "FDA-1987-P-0230", "FDA/Center for Drugs and Biologics - Petition Approval", "Other", "PAV-Petition Approval", "2009-12-23T05:00:00Z", 2009, 12, "2009-12-23T05:00:00Z", null, "2013-07-27T20:47:57Z", null, 0, 0, "090000648046d7d3"], ["FDA-2009-P-0305-0003", "FDA", "FDA-2009-P-0305", "FDA/Center for Devices and Radiological Health Interim Response to  Hygeia II Medical Group Inc.", "Other", "LET-Letter", "2009-12-23T05:00:00Z", 2009, 12, "2009-12-23T05:00:00Z", null, "2013-08-11T01:31:35Z", null, 0, 0, "0900006480a6b1c4"], ["FDA-1987-P-0230-0003", "FDA", "FDA-1987-P-0230", "Acknowledgement Letter to Sidmak Laboratories Inc", "Other", "ACK-Acknowledgement Letter", "2009-12-23T05:00:00Z", 2009, 12, "2009-12-23T05:00:00Z", null, "2009-12-23T17:23:52Z", null, 0, 0, "0900006480a707a1"], ["FDA-2008-D-0399-0007", "FDA", "FDA-2008-D-0399", "Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions, Annex 5 Disintegration Test General Chapter - Guidance for Industry", "Other", "GDL-Guidance (Supporting and Related Materials)", "2009-12-23T05:00:00Z", 2009, 12, "2009-12-23T05:00:00Z", null, "2024-11-12T04:49:00Z", null, 1, 0, "0900006480a70857"], ["FDA-1987-P-0230-0001", "FDA", "FDA-1987-P-0230", "Sidmak Laboratories, Inc - Citizen Petition", "Other", "CP-Citizen Petition", "2009-12-23T05:00:00Z", 2009, 12, "2009-12-23T05:00:00Z", null, "2013-07-27T20:47:57Z", null, 0, 0, "090000648046d7d2"], ["FDA-2009-D-0588-0002", "FDA", "FDA-2009-D-0588", "Guidance for Industry on the Timeframe for Submission of Tobacco Health Documents - Guidance", "Other", "GDL-Guidance (Supporting and Related Materials)", "2009-12-22T05:00:00Z", 2009, 12, "2009-12-22T05:00:00Z", null, "2024-11-07T22:11:18Z", null, 1, 0, "0900006480a6f5bc"], ["FDA-2009-D-0013-0005", "FDA", "FDA-2009-D-0013", "International Conference on Harmonisation: Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions - Guidance", "Other", "GDL-Guidance (Supporting and Related Materials)", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2024-11-07T22:13:57Z", null, 1, 0, "0900006480a6f8f1"], ["FDA-2009-P-0405-0021", "FDA", "FDA-2009-P-0405", "Consumers Union and Food Animal Concerns Trust (FACT) [Multiple Names=37,170 Citizens] - Letter", "Other", "LET-Letter", "2009-12-18T05:00:00Z", 2009, 12, "2009-12-18T05:00:00Z", null, "2010-01-05T22:42:57Z", null, 0, 0, "0900006480a6e1f4"], ["FDA-2003-M-0501-0003", "FDA", "FDA-2003-M-0501", "DUPLICATE", "Other", "AAV-Approval of Application", "2009-12-18T05:00:00Z", 2009, 12, "2009-12-18T05:00:00Z", null, "2025-04-01T19:30:11Z", null, 0, 0, "09000064804a2b21"], ["FDA-2003-M-0501-0002", "FDA", "FDA-2003-M-0501", "Premarket Approval Response Letter from FDA CDRH to Boston Scientific Scimed, Inc.", "Other", "Approval", "2009-12-18T05:00:00Z", 2009, 12, "2009-12-18T05:00:00Z", null, "2025-04-01T19:34:05Z", null, 0, 0, "09000064804a2b1f"], ["FDA-2003-M-0501-0004", "FDA", "FDA-2003-M-0501", "Background Materials re: Premarket Approval Response Letter from FDA CDRH to Boston Scientific Scimed, Inc.", "Other", "Background Material", "2009-12-18T05:00:00Z", 2009, 12, "2009-12-18T05:00:00Z", null, "2025-04-01T19:36:00Z", null, 0, 0, "09000064804a2b22"], ["FDA-2003-P-0127-0004", "FDA", "FDA-2003-P-0127", "The Weinberg Group, Inc.  - Petition Withdrawal re FDA-2003-P-0127-0003", "Other", "WDL-Withdrawal", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", null, "2024-10-30T20:35:50Z", null, 0, 0, "0900006480a6b578"], ["FDA-2009-D-0574-0002", "FDA", "FDA-2009-D-0574", "Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions - Guidance", "Other", "GDL-Guidance (Supporting and Related Materials)", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", "2010-02-17T04:59:59Z", "2009-12-17T20:39:09Z", null, 0, 0, "0900006480a6d53a"], ["FDA-2003-P-0127-0003", "FDA", "FDA-2003-P-0127", "Citizen Petition from The Weinberg Group, Inc.", "Other", "CP-Citizen Petition", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", null, "2024-10-30T20:56:47Z", null, 0, 0, "0900006480486267"], ["FDA-2009-P-0567-0003", "FDA", "FDA-2009-P-0567", "Arent Fox LLP - Withdrawal", "Other", "WDL-Withdrawal", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", null, "2013-07-27T23:02:39Z", null, 0, 0, "0900006480a6ba1b"], ["FDA-2009-P-0273-0004", "FDA", "FDA-2009-P-0273", "FDA/CDER Interim Response to Lachman Consultant Services, Inc. - Letter", "Other", "LET-Letter", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", null, "2013-07-27T23:02:16Z", null, 0, 0, "0900006480a69fe3"], ["FDA-2009-P-0595-0002", "FDA", "FDA-2009-P-0595", "Acknowledgement Letter to Public Citizen Health Research Group", "Other", "ACK-Acknowledgement Letter", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", null, "2009-12-17T23:10:44Z", null, 0, 0, "0900006480a6b5a8"], ["FDA-2009-D-0573-0002", "FDA", "FDA-2009-D-0573", "Addendum To ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals S6(R1) - Guidance", "Other", "GDL-Guidance (Supporting and Related Materials)", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", "2010-02-02T04:59:59Z", "2023-12-21T02:00:44Z", null, 0, 0, "0900006480a6d52c"], ["FDA-2009-P-0595-0001", "FDA", "FDA-2009-P-0595", "Public Citizen Health Research Group - Citizen Petition", "Other", "CP-Citizen Petition", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", null, "2011-01-05T16:57:05Z", null, 0, 0, "0900006480a6b5a7"], ["FDA-2009-D-0579-0002", "FDA", "FDA-2009-D-0579", "Q4B Evaluation and Recommenations of Pharmacopoeial Texts for Use in the ICH Regions - Guidance", "Other", "GDL-Guidance (Supporting and Related Materials)", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", "2010-02-17T04:59:59Z", "2009-12-17T19:31:20Z", null, 0, 0, "0900006480a6cf78"], ["FDA-2009-P-0593-0001", "FDA", "FDA-2009-P-0593", "Grove Medical LLC - Citizen Petition", "Other", null, "2009-12-17T00:00:00Z", 2009, 12, null, null, "2013-08-11T03:05:56Z", null, 0, 1, "0900006480a6b102"], ["FDA-2009-P-0593-0002", "FDA", "FDA-2009-P-0593", "Acknowledgement Letter to Grove Medical LLC", "Other", null, "2009-12-17T00:00:00Z", 2009, 12, null, null, "2013-08-11T03:05:56Z", null, 0, 1, "0900006480a6b103"], ["FDA-2009-P-0589-0001", "FDA", "FDA-2009-P-0589", "Buchanan Ingersoll & Rooney PC - Citizen Petition", "Other", "CP-Citizen Petition", "2009-12-16T05:00:00Z", 2009, 12, "2009-12-16T05:00:00Z", null, "2012-03-09T16:55:44Z", null, 0, 0, "0900006480a62246"], ["FDA-1975-N-0013-0025", "FDA", "FDA-1975-N-0013", "Request for Hearing from Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)", "Other", "Request for Hearing", "2009-12-16T05:00:00Z", 2009, 12, "2009-12-16T05:00:00Z", null, "2017-11-13T19:00:29Z", null, 0, 0, "0900006480a4e166"], ["FDA-2009-P-0185-0003", "FDA", "FDA-2009-P-0185", "Bioniche Pharma, LLC - Amendment", "Other", "AMD-Amendment", "2009-12-16T05:00:00Z", 2009, 12, "2009-12-16T05:00:00Z", null, "2013-07-27T23:01:53Z", null, 0, 0, "0900006480a6714d"], ["FDA-1975-N-0013-0024", "FDA", "FDA-1975-N-0013", "Citizen Petition from Amuchina International, Inc.", "Other", "Citizen Petition", "2009-12-16T05:00:00Z", 2009, 12, "2009-12-16T05:00:00Z", null, "2017-11-16T14:57:17Z", null, 0, 0, "09000064805c1daa"], ["FDA-1977-P-0193-0002", "FDA", "FDA-1977-P-0193", "National Food Processors Association - Supplement", "Other", "Supplement (SUP)", "2009-12-16T05:00:00Z", 2009, 12, "2009-12-16T05:00:00Z", null, "2013-08-13T15:53:38Z", null, 0, 0, "09000064805db3dd"], ["FDA-2009-P-0589-0003", "FDA", "FDA-2009-P-0589", "Acknowledgement Letter to Buchanan Ingersoll & Rooney PC", "Other", "Acknowledgement Letter/Receipt", "2009-12-16T05:00:00Z", 2009, 12, "2009-12-16T05:00:00Z", null, "2013-07-27T23:02:15Z", null, 0, 0, "0900006480a69569"], ["FDA-2009-P-0266-0005", "FDA", "FDA-2009-P-0266", "FDA/CDER Interim Response to Dr. Reddy's Laboratories, Inc. - Letter", "Other", "LET-Letter", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2013-08-11T01:31:24Z", null, 0, 0, "0900006480a661cd"], ["FDA-1995-D-0298-0011", "FDA", "FDA-1995-D-0298", "Alaska Seafood Marketing Institute - Request for Extension Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2013-08-11T02:46:21Z", null, 0, 0, "09000064805998f7"], ["FDA-2009-P-0587-0001", "FDA", "FDA-2009-P-0587", "Buchanan Ingersoll & Rooney PC -  Citizen Petition", "Other", "CP-Citizen Petition", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2013-07-27T23:01:55Z", null, 0, 0, "0900006480a6777c"], ["FDA-2009-P-0362-0011", "FDA", "FDA-2009-P-0362", "Ryszard Rokicki - Supplement Citizen Petition", "Other", "SUP-Supplement", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2013-07-27T23:01:31Z", null, 0, 0, "0900006480a63846"], ["FDA-1995-D-0298-0003", "FDA", "FDA-1995-D-0298", "NFPA, National Food Processors Assn. - Request for Extension Comments", "Other", "EXT-Request for Extension Comment Due Date", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2013-07-27T21:45:00Z", null, 0, 0, "09000064805998f2"], ["FDA-1995-D-0298-0006", "FDA", "FDA-1995-D-0298", "FDA/CFSAN Between MaryLynn Datoc, and Robert L. Collette, and Allen W. Matthys - Memorandum of Telephone Conversations", "Other", "MT-Memorandum of Telephone Conversation", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2009-12-14T18:03:00Z", null, 0, 0, "09000064805998f9"], ["FDA-1995-D-0298-0009", "FDA", "FDA-1995-D-0298", "Pacific Seafood Processors Assn. - Request for Comment Due Data", "Other", "EXT-Request for Extension Comment Due Date", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2013-07-27T21:45:00Z", null, 0, 0, "09000064805998f5"], ["FDA-2008-P-0330-0005", "FDA", "FDA-2008-P-0330", "FDA/CDER Response to Rakoczy Molino Mazzochi Siwik, LLP - Letter", "Other", "LET-Letter", "2009-12-14T05:00:00Z", 2009, 12, null, null, "2013-08-11T04:36:53Z", null, 0, 0, "0900006480a661d0"], ["FDA-2009-N-0374-0016", "FDA", "FDA-2009-N-0374", "Ellen Frank, Director Division of Public Affairs - \"Educating the Public On the Phase-Out of Epinephrine CFC Inhalers\" [Public Workshop, September 25, 2009] - Testimony", "Other", "TS-Testimony", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2013-07-27T23:01:22Z", null, 0, 0, "0900006480a62271"], ["FDA-2009-P-0586-0002", "FDA", "FDA-2009-P-0586", "Acknowledgement Letter to Canada Ice Enterprises", "Other", "ACK-Acknowledgement Letter", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2013-08-11T04:36:55Z", null, 0, 0, "0900006480a67288"], ["FDA-1981-D-0064-0003", "FDA", "FDA-1981-D-0064", "References for Memorandum of March 2, 1979", "Other", "References (External) (REF)", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2026-01-30T22:37:16Z", null, 0, 0, "0900006480a6a243"], ["FDA-1981-D-0064-0002", "FDA", "FDA-1981-D-0064", "Guidance - GDL", "Other", "GDL-Guidance", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2009-12-14T17:00:25Z", null, 0, 0, "0900006480a6a241"], ["FDA-2007-P-0181-0013", "FDA", "FDA-2007-P-0181", "The Lillie Center, Inc. to FDA - Letter", "Other", "LET-Letter", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2013-07-27T23:01:56Z", null, 0, 0, "0900006480a67903"], ["FDA-1995-D-0298-0013", "FDA", "FDA-1995-D-0298", "Ocean Beauty Seafoods, Inc. - Request fo Extension Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2009-12-14T19:28:24Z", null, 0, 0, "0900006480a6a5a4"], ["FDA-1995-D-0298-0002", "FDA", "FDA-1995-D-0298", "National Fisheries Institute, Inc. - Request for  Extension Comment Due Data", "Other", "EXT-Request for Extension Comment Due Date", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2013-07-27T21:45:00Z", null, 0, 0, "09000064805998f1"], ["FDA-1995-D-0298-0005", "FDA", "FDA-1995-D-0298", "FDA/CFSAN Between MaryLynn Datoc, and Jim Yonker and Vincent A. Curry and Kevin O'Sullivan - Memorandum of Telephone Conversations", "Other", "MT-Memorandum of Telephone Conversation", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2009-12-14T18:02:20Z", null, 0, 0, "09000064805998fa"], ["FDA-2004-P-0279-0007", "FDA", "FDA-2004-P-0279", "Letter from the Center for Science in the Public Interest", "Other", "Letter(s)", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2025-01-30T00:29:49Z", null, 0, 0, "0900006480a637bc"], ["FDA-1995-D-0298-0007", "FDA", "FDA-1995-D-0298", "FDA/CFSAN to Christopher E. Rezendes, Seafood Team Leader", "Other", "M-Memorandum", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2009-12-14T18:06:30Z", null, 0, 0, "09000064805998fb"], ["FDA-1995-D-0298-0014", "FDA", "FDA-1995-D-0298", "Compliance Policy Guide - Guidance", "Other", "GDL-Guidance", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2009-12-14T19:32:50Z", null, 0, 0, "0900006480a6a5f9"], ["FDA-1981-D-0064-0004", "FDA", "FDA-1981-D-0064", "Reference 1 - Westgate Foods - F.D.C. #57693, summarized in FDA Consumer, Oct 1. 1974- [ Background Material - BKG]", "Other", "BKG-Background Material", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2009-12-14T17:00:28Z", null, 0, 0, "0900006480a6a248"], ["FDA-2009-P-0586-0001", "FDA", "FDA-2009-P-0586", "Canada Ice Enterprises - Citizen Petition", "Other", "CP-Citizen Petition", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2024-11-12T04:49:03Z", null, 1, 0, "0900006480a67284"], ["FDA-2009-P-0587-0004", "FDA", "FDA-2009-P-0587", "Acknowledgement Letter to Buchanan Ingersoll & Rooney PC", "Other", "ACK-Acknowledgement Letter", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2013-08-11T03:05:50Z", null, 0, 0, "0900006480a67922"], ["FDA-2006-P-0518-0005", "FDA", "FDA-2006-P-0518", "George Washington University Medical Center to FDA, December 3, 2009 - Letter re FDA-2006-P-0518-0001", "Other", "LET-Letter", "2009-12-13T05:00:00Z", 2009, 12, "2009-12-13T05:00:00Z", null, "2013-07-27T23:02:07Z", null, 0, 0, "0900006480a68b1b"], ["FDA-2008-P-0560-0005", "FDA", "FDA-2008-P-0560", "FDA/CDER Response to Schiff & Company - Letter", "Other", "LET-Letter", "2009-12-13T05:00:00Z", 2009, 12, "2009-12-13T05:00:00Z", null, "2013-07-27T23:01:53Z", null, 0, 0, "0900006480a6714e"], ["FDA-2009-Q-0301-0013", "FDA", "FDA-2009-Q-0301", "Cover Letter from Nestle Nutrition to FDA/CFSAN - Cover Letter for Redacted Supporting Materials of Qualified Health Claim Petition  - Qualified Health Claim Petition] re FDA-2009-Q-0301-0002", "Other", "LET-Letter", "2009-12-11T05:00:00Z", 2009, 12, "2009-12-11T05:00:00Z", null, "2013-08-11T03:05:52Z", null, 0, 0, "0900006480a69264"], ["FDA-2009-P-0471-0007", "FDA", "FDA-2009-P-0471", "Mark Antell, et al - Supplement", "Other", "SUP-Supplement", "2009-12-11T05:00:00Z", 2009, 12, "2009-12-11T05:00:00Z", null, "2013-07-27T23:00:42Z", null, 0, 0, "0900006480a5dd84"], ["FDA-2004-P-0278-0007", "FDA", "FDA-2004-P-0278", "Center for Science in the Public Interest to FDA - Letter", "Other", "LET-Letter", "2009-12-10T05:00:00Z", 2009, 12, "2009-12-10T05:00:00Z", null, "2025-02-19T16:43:59Z", null, 0, 0, "0900006480a6305a"], ["FDA-1998-D-0025-0037", "FDA", "FDA-1998-D-0025", "Guidance on Pet Drugs --- Current Good Manufacturing Practice (CGMP) - GDL", "Other", "GDL-Guidance (Supporting and Related Materials)", "2009-12-10T05:00:00Z", 2009, 12, "2009-12-10T05:00:00Z", null, "2024-11-07T22:11:10Z", null, 1, 0, "0900006480a686eb"], ["FDA-1977-N-0049-0002", "FDA", "FDA-1977-N-0049", "Internal Memorandum from William E. Gilbertson (HFD-210) to Dockets Management Branch (HFA-305) December 24, 1991", "Other", "Memorandum", "2009-12-10T05:00:00Z", 2009, 12, "2009-12-10T05:00:00Z", null, "2019-02-07T14:57:56Z", null, 0, 0, "0900006480a68e9d"], ["FDA-1995-S-0039-0224", "FDA", "FDA-1995-S-0039", "NDI 586 -  Oxaloacetic Acid from Terra Biological LLC", "Other", "75 Day PreMarket Notification", "2009-12-09T05:00:00Z", 2009, 12, "2009-12-09T05:00:00Z", null, "2016-09-30T14:23:36Z", null, 0, 0, "0900006480a2eb6f"], ["FDA-2009-P-0558-0003", "FDA", "FDA-2009-P-0558", "Lachman Consultant Services, Inc. - Withdrawal", "Other", "WDL-Withdrawal", "2009-12-09T05:00:00Z", 2009, 12, "2009-12-09T05:00:00Z", null, "2013-08-11T04:36:50Z", null, 0, 0, "0900006480a63464"], ["FDA-2008-P-0542-0008", "FDA", "FDA-2008-P-0542", "FDA/CFSAN Response to Coburn & Coffman PLLC - Petition Denial", "Other", "PDN-Petition Denial", "2009-12-09T05:00:00Z", 2009, 12, "2009-12-09T05:00:00Z", null, "2013-07-27T23:01:55Z", null, 0, 0, "0900006480a67862"], ["FDA-1995-S-0039-0233", "FDA", "FDA-1995-S-0039", "Letter from  FDA/CFSAN to Shannon Minerals Ltd.  re NDI 305 -  Extract of Garcinia Cambogia (Burren Spring Trim)", "Other", "Supplement (SUP)", "2009-12-09T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:38Z", null, 0, 0, "0900006480a6272c"], ["FDA-1995-S-0039-0230", "FDA", "FDA-1995-S-0039", "NDI 587 - Androsta-1,4,6-triene-3,17-dione  from Proprietary Wellness", "Other", "75 Day PreMarket Notification", "2009-12-09T05:00:00Z", 2009, 12, "2009-12-09T05:00:00Z", null, "2016-09-30T14:23:37Z", null, 0, 0, "0900006480a2bc6d"], ["FDA-2009-P-0581-0015", "FDA", "FDA-2009-P-0581", "Acknowledgement Letter to Bayer HealthCare LLC (Ropes & Gray, LLP)", "Other", "ACK-Acknowledgement Letter", "2009-12-09T05:00:00Z", 2009, 12, "2009-12-09T05:00:00Z", null, "2013-08-11T04:36:50Z", null, 0, 0, "0900006480a6357c"], ["FDA-1995-S-0039-0232", "FDA", "FDA-1995-S-0039", "Letter from  FDA/CFSAN to Shannon Minerals Ltd.  re NDI 304 - Extract of Garcinia Cambogia (Coolwater Trim)", "Other", "Supplement (SUP)", "2009-12-09T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:38Z", null, 0, 0, "0900006480a6272b"], ["FDA-2009-P-0259-0003", "FDA", "FDA-2009-P-0259", "FDA/CDER Interim Response to Akorn, Inc. - Letter", "Other", "LET-Letter", "2009-12-09T05:00:00Z", 2009, 12, "2009-12-09T05:00:00Z", null, "2013-08-11T01:31:21Z", null, 0, 0, "0900006480a62241"], ["FDA-2009-P-0581-0001", "FDA", "FDA-2009-P-0581", "Bayer HealthCare LLC (Ropes & Gray, LLP) - Citizen Petition", "Other", "CP-Citizen Petition", "2009-12-09T05:00:00Z", 2009, 12, "2009-12-09T05:00:00Z", null, "2013-12-08T02:21:43Z", null, 0, 0, "0900006480a63509"], ["FDA-2020-D-1381-0001", "FDA", "FDA-2020-D-1381", "Guidance PET Drugs \u2014 Current Good Manufacturing Practice (CGMP)", "Other", "Guidance", "2009-12-09T05:00:00Z", 2009, 12, "2009-12-09T05:00:00Z", null, "2024-11-06T23:36:02Z", null, 1, 0, "09000064845e6c9d"], ["FDA-2009-E-0175-0008", "FDA", "FDA-2009-E-0175", "U.S. Patent and Trademark Office to FDA/CDER - Letter", "Other", "LET-Letter", "2009-12-08T05:00:00Z", 2009, 12, "2009-12-08T05:00:00Z", null, "2013-07-27T23:01:42Z", null, 0, 0, "0900006480a666a0"], ["FDA-1984-P-0033-0016", "FDA", "FDA-1984-P-0033", "FDA/CDER and Upjohn Company, March 21, 1984 - Memorandum of Telephone Conversation", "Other", "MT-Memorandum of Telephone Conversation", "2009-12-08T05:00:00Z", 2009, 12, null, null, "2013-07-27T21:48:42Z", null, 0, 0, "09000064805a8227"], ["FDA-1984-P-0033-0009", "FDA", "FDA-1984-P-0033", "Johnson & Johnson and McNeil Consumer Products Company Meeting with FDA - Memorandum of Meeting (2)", "Other", "MM-Memorandum of Meeting", "2009-12-08T05:00:00Z", 2009, 12, "2009-12-08T05:00:00Z", null, "2013-07-27T21:48:41Z", null, 0, 0, "09000064805a8220"], ["FDA-2009-E-0164-0004", "FDA", "FDA-2009-E-0164", "U.S. Patent and Trademark Office to FDA/CDER - Letter", "Other", "LET-Letter", "2009-12-08T05:00:00Z", 2009, 12, "2009-12-08T05:00:00Z", null, "2013-07-27T23:01:45Z", null, 0, 0, "0900006480a667cf"], ["FDA-2009-E-0202-0005", "FDA", "FDA-2009-E-0202", "U.S. Patent and Trademark Office to FDA/CDER - Letter", "Other", "LET-Letter", "2009-12-08T05:00:00Z", 2009, 12, "2009-12-08T05:00:00Z", null, "2013-07-27T23:01:45Z", null, 0, 0, "0900006480a667d1"], ["FDA-1984-P-0033-0010", "FDA", "FDA-1984-P-0033", "FDA Response to Johnson and Johnson, May 18, 1984 - Letter", "Other", "LET-Letter", "2009-12-08T05:00:00Z", 2009, 12, null, null, "2013-07-27T21:48:41Z", null, 0, 0, "09000064805a8221"], ["FDA-2009-E-0079-0004", "FDA", "FDA-2009-E-0079", "U.S. Patent and Trademark Office to FDA/CDER - Letter", "Other", "LET-Letter", "2009-12-08T05:00:00Z", 2009, 12, "2009-12-08T05:00:00Z", null, "2013-08-11T03:05:48Z", null, 0, 0, "0900006480a666a2"], ["FDA-2009-E-0174-0006", "FDA", "FDA-2009-E-0174", "U.S. Patent and Trademark Office to FDA/CDER - Letter", "Other", "LET-Letter", "2009-12-08T05:00:00Z", 2009, 12, "2009-12-08T05:00:00Z", null, "2013-08-11T01:31:25Z", null, 0, 0, "0900006480a66518"], ["FDA-1984-P-0033-0011", "FDA", "FDA-1984-P-0033", "FDA/CDER Response to Upjohn Manufacturing Company, May 18, 1984 - Letter", "Other", "LET-Letter", "2009-12-08T05:00:00Z", 2009, 12, "2009-12-08T05:00:00Z", null, "2013-07-28T01:48:13Z", null, 0, 0, "09000064805a8222"], ["FDA-1984-P-0033-0008", "FDA", "FDA-1984-P-0033", "Johnson & Johnson to FDA - Letter", "Other", "LET-Letter", "2009-12-08T05:00:00Z", 2009, 12, "2009-12-08T05:00:00Z", null, "2013-08-11T02:47:22Z", null, 0, 0, "09000064805a821f"], ["FDA-1984-P-0033-0013", "FDA", "FDA-1984-P-0033", "FDA/CDER Response to Upjohn Company, March 20, 1984 - Letter", "Other", "LET-Letter", "2009-12-08T05:00:00Z", 2009, 12, null, null, "2013-07-27T21:48:42Z", null, 0, 0, "09000064805a8224"], ["FDA-1984-P-0033-0015", "FDA", "FDA-1984-P-0033", "FDA/Chief Counsel Response to the Federal Trade Commission, March 20, 1984 - Letter", "Other", "LET-Letter", "2009-12-08T05:00:00Z", 2009, 12, "2009-12-08T05:00:00Z", null, "2013-07-27T21:48:42Z", null, 0, 0, "09000064805a8226"]], "truncated": false, "filtered_table_rows_count": 3148, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Other", "p2": "2009"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2009", "results": [{"value": "FDA", "label": "FDA", "count": 3148, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Other&posted_year=2009", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2009", "results": [{"value": "Other", "label": "Other", "count": 3148, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2009", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2009", "results": [{"value": 2009, "label": 2009, "count": 3148, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2009&_facet=posted_month"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2009&_facet=comment_end_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2009&_facet=open_for_comment"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2009&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2009&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2009&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2009&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2009&_facet_date=last_modified"}], "next": "2009-12-08T05~3A00~3A00Z,FDA-1984-P-0033-0015", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2009&_next=2009-12-08T05~3A00~3A00Z%2CFDA-1984-P-0033-0015&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 1391.3282619323581, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}